Privium Fund Management B.V.
13F Reported Value
ⓘ$544.2M
Holdings
61
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Privium Fund Management B.V. disclosed 61 positions worth $544.2M in its Form 13F-HR for Q2 2026, led by $TSLA (Tesla, Inc.) at 17.6% of the equity portfolio, followed by $SHOP and $AMD. During the quarter the fund opened 10 new positions and exited 9 — including a new stake in $OPEN and a full exit from $COIN. The portfolio is most concentrated in Healthcare (32.6% of disclosed assets). All figures are sourced directly from Privium Fund Management B.V.’s Form 13F-HR filing with the SEC under CIK 1795097.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 53.9#1,360
Quality
$95.9M228,000 sh - 64.9#490
Quality
$42.2M370,000 sh - 79.8#32
Quality
$36.0M62,000 sh - 68.7
Quality
$33.4M140,000 sh - 23.4
Quality
$25.4M319,924 sh - —
Quality
$25.3M55,000 sh - 84.6
Quality
$23.3M200,000 sh - 38.7
Quality
$19.1M234,222 sh - 22.5
Quality
$18.2M3,940,904 sh - 50.2
Quality
$17.6M270,259 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Tesla, Inc.$TSLA | 53.9#1,360 | $95.9M | 228,000 |
 SHOPIFY INC.$SHOP | 64.9#490 | $42.2M | 370,000 |
 ADVANCED MICRO DEVICES INC$AMD | 79.8#32 | $36.0M | 62,000 |
 AMAZON COM INC$AMZN | 68.7 | $33.4M | 140,000 |
 IONIS PHARMACEUTICALS INC$IONS | 23.4 | $25.4M | 319,924 |
 Spotify Technology S.A.$SPOT | — | $25.3M | 55,000 |
 Palantir Technologies Inc.$PLTR | 84.6 | $23.3M | 200,000 |
 ARROWHEAD PHARMACEUTICALS, INC.$ARWR | 38.7 | $19.1M | 234,222 |
 Opendoor Technologies Inc.$OPEN | 22.5 | $18.2M | 3,940,904 |
 Lemonade, Inc.$LMND | 50.2 | $17.6M | 270,259 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Privium Fund Management B.V.'s 61 positions.
Showing top 10 of 61 holdings.
Sector Allocation
Healthcare
$177.6M
Technology
$138.0M
Industrials
$96.5M
Communication Services
$38.1M
Consumer Discretionary
$34.1M
Financials
$33.7M
Real Estate
$18.2M
Consumer Staples
$4.0M
Full Holdings — Privium Fund Management B.V. (Q2 2026)
All 61 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $TSLA | Tesla, Inc. | $95.9M | 17.6% | +3% | 53.9 |
| 2 | $SHOP | SHOPIFY INC. | $42.2M | 7.8% | -9% | 64.9 |
| 3 | $AMD | ADVANCED MICRO DEVICES INC | $36.0M | 6.6% | +0% | 79.8 |
| 4 | $AMZN | AMAZON COM INC | $33.4M | 6.1% | +12% | 68.7 |
| 5 | $IONS | IONIS PHARMACEUTICALS INC | $25.4M | 4.7% | +10% | 23.4 |
| 6 | $SPOT | Spotify Technology S.A. | $25.3M | 4.6% | -18% | — |
| 7 | $PLTR | Palantir Technologies Inc. | $23.3M | 4.3% | +0% | 84.6 |
| 8 | $ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $19.1M | 3.5% | -36% | 38.7 |
| 9 | $OPEN | Opendoor Technologies Inc. | $18.2M | 3.4% | NEW | 22.5 |
| 10 | $LMND | Lemonade, Inc. | $17.6M | 3.2% | +6% | 50.2 |
| 11 |  $NVDA | NVIDIA CORP | $16.2M | 3.0% | +0% | 85.9 |
| 12 |  $IREN | IREN Ltd | $15.6M | 2.9% | +6% | 46.3 |
| 13 |  $QURE | uniQure N.V. | $15.1M | 2.8% | -33% | — |
| 14 |  $CBRS | Cerebras Systems Inc. | $13.4M | 2.5% | NEW | — |
| 15 |  $ASTS | AST SpaceMobile, Inc. | $12.9M | 2.4% | +0% | 30.8 |
| 16 |  $RARE | Ultragenyx Pharmaceutical Inc. | $11.3M | 2.1% | -7% | 34.2 |
| 17 |  $ARQT | Arcutis Biotherapeutics, Inc. | $10.5M | 1.9% | +24% | 62.9 |
| 18 |  $BIIB | BIOGEN INC. | $10.5M | 1.9% | +11% | 64.7 |
| 19 |  $PRQR | ProQR Therapeutics N.V. | $10.3M | 1.9% | +1% | — |
| 20 |  $AXSM | Axsome Therapeutics, Inc. | $9.8M | 1.8% | -32% | 40.8 |
| 21 |  $URGN | UroGen Pharma Ltd. | $7.7M | 1.4% | -12% | — |
| 22 |  $SPCX | SPACE EXPLORATION TECHNOLOGIES CORP | $6.8M | 1.3% | NEW | — |
| 23 |  $DNLI | Denali Therapeutics Inc. | $5.9M | 1.1% | -10% | — |
| 24 |  $VRTX | VERTEX PHARMACEUTICALS INC / MA | $4.7M | 0.9% | -17% | 75.4 |
| 25 |  $BMRN | BIOMARIN PHARMACEUTICAL INC | $4.3M | 0.8% | -19% | 58.2 |
| 26 |  $KRYS | Krystal Biotech, Inc. | $4.2M | 0.8% | +0% | 79.2 |
| 27 |  $ALNY | ALNYLAM PHARMACEUTICALS, INC. | $3.4M | 0.6% | -7% | 71.4 |
| 28 |  $VRDN | Viridian Therapeutics, Inc.\DE | $3.2M | 0.6% | +0% | 27.2 |
| 29 |  $BNTX | BioNTech SE | $2.8M | 0.5% | +11% | — |
| 30 |  $HIMS | Hims & Hers Health, Inc. | $2.8M | 0.5% | +100% | 53.4 |
| 31 |  $MGTX | MeiraGTx Holdings plc | $2.6M | 0.5% | -8% | — |
| 32 |  $ABEV | AMBEV S.A. | $2.5M | 0.5% | -15% | — |
| 33 |  $SRPT | Sarepta Therapeutics, Inc. | $2.5M | 0.5% | +197% | 47.3 |
| 34 |  $CRSP | CRISPR Therapeutics AG | $2.5M | 0.5% | +5% | 9.7 |
| 35 |  $BEAM | Beam Therapeutics Inc. | $2.4M | 0.4% | +10% | 34.2 |
| 36 |  $ZLAB | Zai Lab Ltd | $2.3M | 0.4% | -8% | — |
| 37 |  $MRNA | Moderna, Inc. | $2.1M | 0.4% | +0% | 21.2 |
| 38 |  $RNAC | Cartesian Therapeutics, Inc. | $1.6M | 0.3% | -15% | 8 |
| 39 |  $MICC | Magnum Ice Cream Co N.V. | $1.5M | 0.3% | NEW | — |
| 40 |  $WVE | Wave Life Sciences, Inc. | $1.4M | 0.3% | +0% | 7.5 |
| 41 |  $TSHA | Taysha Gene Therapies, Inc. | $1.4M | 0.3% | +9% | 4.9 |
| 42 |  $ZTS | Zoetis Inc. | $1.2M | 0.2% | NEW | 68.6 |
| 43 |  $FDMT | 4D Molecular Therapeutics, Inc. | $1.2M | 0.2% | -47% | 34.5 |
| 44 |  $FATE | FATE THERAPEUTICS INC | $1.1M | 0.2% | +0% | 9.2 |
| 45 |  $LEGN | Legend Biotech Corp | $1.0M | 0.2% | NEW | 47.8 |
| 46 |  $RCKT | ROCKET PHARMACEUTICALS, INC. | $834,979 | 0.1% | +1% | — |
| 47 |  $NOV | NOV Inc. | $779,582 | 0.1% | +0% | 47.8 |
| 48 |  $BTG | B2GOLD CORP | $729,610 | 0.1% | +102% | — |
| 49 |  $TTE | TotalEnergies SE | $729,486 | 0.1% | NEW | 50.6 |
| 50 |  $LXEO | Lexeo Therapeutics, Inc. | $722,300 | 0.1% | -24% | — |
| 51 |  $RIG | Transocean Ltd. | $712,004 | 0.1% | +37% | — |
| 52 |  $MOH | MOLINA HEALTHCARE, INC. | $681,297 | 0.1% | -63% | 56.5 |
| 53 |  $NU | Nu Holdings Ltd. | $587,840 | 0.1% | NEW | — |
| 54 |  $AUTL | Autolus Therapeutics plc | $581,488 | 0.1% | +0% | — |
| 55 |  $TDW | TIDEWATER INC | $578,548 | 0.1% | +58% | 64.3 |
| 56 |  $LULU | lululemon athletica inc. | $578,093 | 0.1% | NEW | 67.7 |
| 57 |  $SD | SANDRIDGE ENERGY INC | $531,450 | 0.1% | +0% | 65.2 |
| 58 |  $SA | SEABRIDGE GOLD INC | $425,019 | 0.1% | -33% | — |
| 59 |  $VYGR | Voyager Therapeutics, Inc. | $420,000 | 0.1% | +0% | 8.1 |
| 60 |  $ENGN | enGene Therapeutics Inc. | $294,100 | 0.1% | -52% | — |
| 61 |  $CSAN | Cosan S.A. | $149,760 | 0.0% | NEW | — |
New Positions (10)
$OPEN Opendoor Technologies Inc.$18.2M$CBRS Cerebras Systems Inc.$13.4M$SPCX SPACE EXPLORATION TECHNOLOGIES CORP$6.8M$MICC Magnum Ice Cream Co N.V.$1.5M$ZTS Zoetis Inc.$1.2M$LEGN Legend Biotech Corp$1.0M$TTE TotalEnergies SE$729,486$NU Nu Holdings Ltd.$587,840$LULU lululemon athletica inc.$578,093$CSAN Cosan S.A.$149,760
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Privium Fund Management B.V. including:
Track Privium Fund Management B.V.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Privium Fund Management B.V. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Privium Fund Management B.V.
13F Pro is an AI hedge fund tracker and stock research platform. For Privium Fund Management B.V. (SEC CIK: 1795097), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Privium Fund Management B.V.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.